Profile picture of The Hill (newspaper)
Fears grow over Comstock Act, Justices Thomas, Alito: Abortion rights supporters are sounding the alarm that conservative Supreme Court justices want to use a ...
thehill.com/policy/healthcare/4560476-fears-grow-over-comstock-act-justices-thomas-alito/
Fears grow over Comstock Act, Justices Thomas, Alito
Quick Glance: The Significance of the Supreme Court Mifepristone Case
  • On June 24, 2022, the constitutional jurisprudence on abortions was overturned by the Supreme Court.

  • A pivotal aspect in the dispute FDA v. Alliance for Hippocratic Medicine revolves around making access to medication abortions more challenging.

  • The decision could impact not only abortion access but also have implications for miscarriage treatment.

  • There are also repercussions for the entire country, voters' preferences in blue states, and state sovereignty.
Profile picture of CNN.com
FDA renews proposed ban on electrical stimulation devices: The US Food and Drug Administration is again proposing a ban on electrical stimulation devices used to ...
cnn.com/2024/03/25/health/fda-ban-electrical-stimulation-devices/
FDA renews proposed ban on electrical stimulation devices
Profile picture of Healthline
Elon Musk Takes Ketamine to Help Treat Depression: Does It Work?: In a recent interview, Elon Musk revealed he takes ketamine to help boost his mental health and ...
healthline.com/health-news/elon-musk-ketamine-depression-treatment
Elon Musk Takes Ketamine to Help Treat Depression: Does It Work?
Profile picture of CNN.com
FDA settles lawsuit over ivermectin content that doctors claimed harmed their practice
cnn.com/2024/03/27/health/fda-ivermectin-lawsuit/
FDA settles lawsuit over ivermectin content that doctors claimed harmed ...
Profile picture of Reuters
US FDA approves first drug for fatty liver disease NASH: The U.S. FDA has approved Madrigal Pharmaceuticals' drug for a fatty liver disease known as ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-first-drug-fatty-liver-disease-nash-2024-03-14/
US FDA approves first drug for fatty liver disease NASH
Quick Glance: First Drug Approval for Fatty Liver Disease NASH by US FDA
  • The US FDA has approved Madrigal Pharmaceuticals' drug for the fatty liver disease NASH.

  • NASH, now known as metabolic dysfunction-associated steatohepatitis (MASH), affects about 1.5 million Americans.

  • The drug will be available in April and is seen as a pivotal moment for patients.

  • Other companies are also conducting trials of their drugs for NASH to meet the much-needed treatment.
Profile picture of NPR
Wegovy is now covered by Medicare, but not for weight loss | Here & Now: Wegovy will be covered to prevent heart problems in people with obesity and heart ...
wbur.org/hereandnow/2024/03/26/wegovy-medicare-weight-loss
Wegovy is now covered by Medicare, but not for weight loss | Here & Now
Profile picture of Los Angeles Times
Hiltzik: The FDA and a bogus COVID treatment : Three right-wing doctors said the FDA's advice against taking ivermectin for COVID infringed on their rights ...
latimes.com/business/story/2024-03-26/column-the-fda-shoots-itself-in-the-foot-by-settling-a-dumb-lawsuit-over-ivermectin
Hiltzik: The FDA and a bogus COVID treatment
Profile picture of Axios (website)
FDA authorizes drug to boost COVID protection for immunocompromised patients: It will offer added protection to high-risk patients who may have weaker responses ...
axios.com/2024/03/25/covid-antibody-fda
FDA authorizes drug to boost COVID protection for immunocompromised ...
Profile picture of The Washington Post
Medicare plans can cover Wegovy for patients with heart conditions: The federal government said that its prescription drug insurance for seniors will cover the ...
washingtonpost.com/business/2024/03/21/wegovy-medicare-part-d/
Medicare plans can cover Wegovy for patients with heart conditions
Profile picture of CNN.com
Medicare spending on Ozempic and similar diabetes drugs soars, study finds, and it could end up costing seniors
cnn.com/2024/03/26/health/medicare-ozempic-diabetes-drugs-spending/
Medicare spending on Ozempic and similar diabetes drugs soars, study finds ...
Profile picture of Reuters
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns: Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-regenerons-blood-cancer-therapy-2024-03-25/
Regeneron's blood cancer therapy faces setback as FDA raises trial ...
Profile picture of The Washington Post
U.S. abortions reach recent high, with record number done via medication: The increase comes as the U.S. Supreme Court is considering whether to limit access to ...
washingtonpost.com/politics/2024/03/19/abortion-medication-mifepristone-63-percent/
U.S. abortions reach recent high, with record number done via medication
Profile picture of medscape.com
How do biosimilars compare to reference products and generic drugs? Listen to our expert faculty to learn more. ➡️ www.medscape.org/viewarticle/1000238 🌐 Developed in partnership with U.S ...
Profile picture of Axios (website)
FDA advisory panel recommends revision to flu vaccine: VRBPAC on Tuesday recommended that the agency drop the Yamagata part of the flu vaccine.
axios.com/2024/03/06/flu-vaccine-modified-virus
FDA advisory panel recommends revision to flu vaccine
Profile picture of The Guardian
The mifepristone case: abortion and the US supreme court meet again: On Tuesday the justices will hear oral arguments on a rightwing effort to roll back access ...
theguardian.com/world/2023/aug/17/what-abortion-pill-supreme-court-case-access-mifepristone
The mifepristone case: abortion and the US supreme court meet again
Profile picture of CNN.com
FDA approved a lifesaving therapy for children with a rare genetic disease. It might become the world’s most expensive drug
cnn.com/2024/03/19/health/gene-therapy-orchard-mld/
FDA approved a lifesaving therapy for children with a rare genetic disease ...
Profile picture of The Wall Street Journal
How Telehealth Widens Access to the Abortion Pill: Without telehealth, one in seven women would have to drive over 200 miles to the nearest provider
wsj.com/us-news/supreme-court-abortion-pill-ruling-access-9a5597e3
How Telehealth Widens Access to the Abortion Pill
Profile picture of Newsweek
Medicare Gets Big Change: Wegovy, a weight-loss drug, has been approved for coverage for patients on Medicare who have a history of heart disease.
newsweek.com/wegovy-approved-medicare-insurance-heart-disease-1883177
Medicare Gets Big Change
Profile picture of NPR
In a pandemic milestone, the NIH ends guidance on COVID treatment: The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines ...
npr.org/sections/health-shots/2024/03/19/1239276507/nih-covid-treatment-guidelines
In a pandemic milestone, the NIH ends guidance on COVID treatment
Profile picture of Axios (website)
Military flags risks in drug supply chain: Just a quarter of essential medicines are sourced in the U.S., a Pentagon review found.
axios.com/2024/03/20/military-drug-shortages
Military flags risks in drug supply chain
Profile picture of Reuters
US FDA staff flags concerns about Geron's anemia treatment: The U.S. health regulator's staff on Tuesday flagged concerns that the late-stage trial data on ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flags-concerns-about-gerons-anemia-treatment-2024-03-12/
US FDA staff flags concerns about Geron's anemia treatment
Profile picture of IEEE Spectrum
Pressure-Relief Eye Tech Advances Toward Approval: FDA panel’s green light on glaucoma wearable device offers hope in sight
spectrum.ieee.org/glaucoma-treatment-device
Pressure-Relief Eye Tech Advances Toward Approval
Profile picture of CNBC
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
cnbc.com/2024/03/19/healthy-returns-first-nash-liver-disease-drug-is-here-more-coming.html
Healthy Returns: The first drug for a common, deadly liver disease is here ...
Profile picture of Axios (website)
Growing market for glucose monitoring fueled by nondiabetics: Weight-loss drugs are helping fuel broader interest in the devices, even as many doctors have mixed ...
axios.com/2024/03/19/glucose-monitoring-blood-sugar-diabetes
Growing market for glucose monitoring fueled by nondiabetics
Profile picture of The Atlantic
The Ozempic Revolution Is Stuck: Millions more Americans are now eligible for obesity drugs. But the injections remain maddeningly hard to find.
theatlantic.com/health/archive/2024/03/ozempic-revolution-stuck/677736/
The Ozempic Revolution Is Stuck
Profile picture of Bloomberg
Zepbound Shortage: Eli Lilly Weight-Loss Drug Faces Backorders: Eli Lilly’s new weight-loss shot is on backorder across the US, even as the FDA says there’s ...
bloomberg.com/news/articles/2024-03-26/zepbound-shortage-eli-lilly-weight-loss-drug-faces-backorders
Zepbound Shortage: Eli Lilly Weight-Loss Drug Faces Backorders
Profile picture of Seventeen (American magazine)
Women Can Now Access Birth Control Without a Prescription in New York: A new ruling allows pharmacists to dispense the drug—even for out-of-staters.
harpersbazaar.com/culture/politics/a60254800/women-access-birth-control-without-prescription-new-york/
Women Can Now Access Birth Control Without a Prescription in New York
Profile picture of Investor's Business Daily
Diabetes Play Tops Buy Point In Rally To New Highs: Dexcom stock: The diabetes play rallied to new highs this week, topping a new buy point in the wake of the ...
investors.com/stock-lists/sector-leaders/dexcom-dxcm-stock/
Diabetes Play Tops Buy Point In Rally To New Highs
Profile picture of WTVF
There's a new drug in the fight against COVID. Pemgarda is an infusion drug made for those who are immunocompromised. This week ... Show more
Profile picture of Nikkei Asia
India pharma quality lapses force U.S. to look to China for vital drugs: In the final weeks of 2022, a small team of inspectors from the U.S ...
asia.nikkei.com/Spotlight/Special-Reports/India-pharma-quality-lapses-force-U.S.-to-look-to-China-for-vital-drugs
India pharma quality lapses force U.S. to look to China for vital drugs
Profile picture of RAPPLER
FACT CHECK: Unregistered anti-itch not endorsed by Doc Liza Ong: The Philippine Food and Drug Administration has not approved the product Arturo Doctor Zu ...
rappler.com/newsbreak/fact-check/unregistered-anti-itch-not-endorsed-doc-liza-ong/
FACT CHECK: Unregistered anti-itch not endorsed by Doc Liza Ong
Profile picture of Modern Healthcare
How healthcare AI is regulated by the FDA, HHS, state laws: Widespread oversight of artificial intelligence in healthcare is a work in progress but there are ...
modernhealthcare.com/digital-health/healthcare-ai-regulation-fda-hhs
How healthcare AI is regulated by the FDA, HHS, state laws
Profile picture of Financialexpress
USFDA gives nod to nonsteroidal treatment for Duchenne Muscular Dystrophy: The FDA granted this application priority review and fast track designation ...
financialexpress.com/healthcare/pharma-healthcare/fda-gives-nod-to-nonsteroidal-treatment-for-duchenne-muscular-dystrophy/3435687/
USFDA gives nod to nonsteroidal treatment for Duchenne Muscular Dystrophy
Profile picture of Financialexpress
The FDA granted this application priority review and fast track designation. It also received orphan drug and rare pediatric disease designations.
Profile picture of Investor's Business Daily
Radiopharma Space Heats Up As Biotech Rockets 97% on $2 Billion Deal: AstraZeneca said Tuesday is would acquire Fusion Pharmaceuticals for $2 billion upfront ...
investors.com/news/technology/fusion-pharmaceuticals-astrazeneca-acquisition-biotech-stock/
Radiopharma Space Heats Up As Biotech Rockets 97% on $2 Billion Deal
Profile picture of The Punch
NAFDAC raids fake water factory in Rivers, arrests one: The agency said the discovery on Friday morning followed a tip off from some well-meaning members of the ...
punchng.com/nafdac-raids-fake-water-factory-in-rivers-arrests-one/
NAFDAC raids fake water factory in Rivers, arrests one
Profile picture of NPR
First over-the-counter birth control pill now for sale online: Opill, an over-the-counter birth control pill, goes on sale online today. The pill is expected to ...
npr.org/sections/health-shots/2024/03/04/1235404522/opill-over-counter-birth-control-pill-contraceptive-shop
First over-the-counter birth control pill now for sale online
Profile picture of Bloomberg
Oprah’s Ozempic Special Was a Missed Opportunity for Obesity: The Queen of All Media is trying to reset our national conversation about body size ...
bloomberg.com/opinion/articles/2024-03-19/oprah-s-ozempic-special-was-a-missed-opportunity-for-obesity
Oprah’s Ozempic Special Was a Missed Opportunity for Obesity
Profile picture of The Atlanta Journal-Constitution
Opinion: Menthol cigarettes are menace to Black community: As executive director for the Center for Black Health & Equity, I’ve witnessed the devastating health ...
ajc.com/opinion/opinion-menthol-cigarettes-are-menace-to-black-community/CK5T5YSZBJFXTGS33ZA3O6EB7Y/
Opinion: Menthol cigarettes are menace to Black community
Profile picture of Bloomberg
Wegovy (NOVOB DC) for Heart Disease Now Covered by Medicare Part D Plans: Medicare prescription drug programs can now cover Novo Nordisk A/S’s blockbuster ...
bloomberg.com/news/articles/2024-03-21/medicare-drug-plans-can-now-cover-wegovy-for-heart-disease
Wegovy (NOVOB DC) for Heart Disease Now Covered by Medicare Part D Plans
Profile picture of The Oklahoman
Dozens sue saying Ozempic, other weight loss and diabetes drugs cause harmful side effects
usatoday.com/story/news/health/2024/03/21/lawsuits-ozempic-wegovy-weight-loss-drugs-diabetes-harmful/72947158007/
Dozens sue saying Ozempic, other weight loss and diabetes drugs cause ...
Profile picture of Fast Company
Novo Nordisk’s weight-loss wonder drugs could also help with dementia, liver disease, and more
fastcompany.com/91042014/novo-nordisk-most-innovative-companies-2024
Novo Nordisk’s weight-loss wonder drugs could also help with dementia ...
Profile picture of The Punch
Obey House resolution, lift sachet alcohol ban, Reps tell NAFDAC: The House of Representatives, on Wednesday, called on the National Agency for Food and Drug ...
punchng.com/obey-house-resolution-lift-sachet-alcohol-ban-reps-tell-nafdac/
Obey House resolution, lift sachet alcohol ban, Reps tell NAFDAC
Profile picture of TheStreet
Trader Joe's is recalling its second food product this month — make sure you don't eat it
thestreet.com/retail/trader-joes-is-recalling-its-second-food-product-this-month
Trader Joe's is recalling its second food product this month — make sure ...
Profile picture of RAPPLER
FACT CHECK: Height Maxx Nutri-C Tall is not FDA approved: The Philippine FDA issued an advisory in August 2023 urging the public to avoid purchasing and ...
rappler.com/newsbreak/fact-check/height-maxx-nutri-c-tall-not-fda-approved/
FACT CHECK: Height Maxx Nutri-C Tall is not FDA approved
Profile picture of medicalnewstoday.com
New weight loss pill amycretin more effective than semaglutide in early trial: Novo Noridisk has announced the results of a phase 1 clinical trial testing their ...
medicalnewstoday.com/articles/new-weight-loss-pill-amycretin-more-effective-than-semaglutide-in-early-trial
New weight loss pill amycretin more effective than semaglutide in early ...
Profile picture of Health
Can Eating Yogurt Really Reduce Your Risk of Diabetes?: The FDA has approved a qualified health claim that yogurt—specifically eating two cups or three servings ...
health.com/yogurt-reduce-diabetes-risk-8606635
Can Eating Yogurt Really Reduce Your Risk of Diabetes?
Profile picture of The Plain Dealer
When diet and exercise aren’t enough, new drug can treat fatty liver disease, says FDA
cleveland.com/news/2024/03/when-diet-and-exercise-arent-enough-new-drug-can-treat-fatty-liver-disease-says-fda.html
When diet and exercise aren’t enough, new drug can treat fatty liver ...
Profile picture of medicalnewstoday.com
How diabetes drug metformin can suppress hunger and help with weight loss: Researchers say the diabetes drug metformin can help people lose weight by increasing ...
medicalnewstoday.com/articles/how-diabetes-drug-metformin-can-suppress-hunger-and-help-with-weight-loss
How diabetes drug metformin can suppress hunger and help with weight loss
Profile picture of Axios (website)
How Medicare can start covering a popular weight-loss drug for more people: The recent approval of Wegovy for heart risks could greatly expand access ...
axios.com/2024/03/14/medicare-weight-loss-drugs-ozempic-wegovy-coverage
How Medicare can start covering a popular weight-loss drug for more people
Profile picture of VentureBeat
Proscia’s $46M Series C propels AI-driven pathology into the mainstream: Proscia raises $9M in Series C extension and secures FDA clearance to accelerate the ...
venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
Proscia’s $46M Series C propels AI-driven pathology into the mainstream
Profile picture of Reuters
US FDA staff raise concerns over data from J&J, Bristol's CAR-T therapies: The U.S. Food and Drug Administration's staff on Wednesday raised concerns that it was ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-staff-flag-safety-concerns-jj-bristols-car-t-therapies-2024-03-13/
US FDA staff raise concerns over data from J&J, Bristol's CAR-T therapies
Profile picture of Bloomberg
Fake Ozempic Shows Dark Side of Weight-Loss Frenzy: Inside the UK task force tackling potentially deadly obesity drug counterfeits
bloomberg.com/news/articles/2024-03-13/fake-ozempic-shows-dark-side-of-weight-loss-frenzy
Fake Ozempic Shows Dark Side of Weight-Loss Frenzy
Profile picture of Euronews
How much higher can Novo Nordisk shares go?: Novo Nordisk's remarkable ascent, driven by its revolutionary weight-loss drug Wegovy ...
euronews.com/business/2024/03/13/how-high-can-novo-nordisk-shares-go
How much higher can Novo Nordisk shares go?
Profile picture of Daily Maverick
Wegovy’s newly verified heart benefits under review by Medicare: The US federal health insurance, Medicare may soon be required to cover the blockbuster ...
dailymaverick.co.za/article/2024-03-12-wegovys-newly-verified-heart-benefits-under-review-by-medicare/
Wegovy’s newly verified heart benefits under review by Medicare